MarketPulse

healthcare sector

8 articles
The Motley FoolThe Motley Fool··Eric Volkman

Healthcare's Dividend Gems: Why $ABBV and $BMY Stand Out for Income Investors

$ABBV and $BMY deliver above-average dividend yields and growth, standing out as rare healthcare sector exceptions for patient income investors navigating patent cliffs through innovation.
BMYCELGrABBVABTdividend stocksdividend growth
The Motley FoolThe Motley Fool··Jonathan Ponciano

Major Investor Bet on Organon Stock Signals Turnaround Faith Despite 61% Collapse

Sio Capital Management invested $24.53 million in Organon ($OGN) at $6.03/share, betting on turnaround potential despite 61% annual decline. Company maintains flat 2026 guidance with $1.9B adjusted EBITDA.
OGNvalue investinginstitutional investment
The Motley FoolThe Motley Fool··Bram Berkowitz

Small-Cap Opportunity: Why Russell 2000 Deserves a Second Look Despite Headwinds

Small-cap stocks offer compelling valuations and diversification benefits despite near-term headwinds; long-term investors may find opportunity in underperformance.
VTWOlong-term investingoil prices
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Healthcare Giants BDX and MDT Offer Dividend Appeal Below $1,000 Each

Becton Dickinson and Medtronic offer attractive dividend yields of 2.4% and 2.9%, trading below $1,000 with growth potential amid sector pessimism.
MDTISRGBDXdividend stockslong-term investing
Investing.comInvesting.com··Jeffrey Neal Johnson

Healthcare Giant Johnson & Johnson Outpaces Tech Sector on Dividend Strength

J&J stock hits record highs with 14% monthly returns, outperforming tech due to stable dividends, strong cash flow, and lower volatility amid market uncertainty.
JNJdividend growthpharmaceutical innovation
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Novartis Maintains Growth Trajectory Amid Patent Challenges, Dividend Consistency

Novartis maintains growth despite patent challenges, backed by a strong product portfolio of 15 billion-dollar brands and nearly 30 years of consecutive dividend increases.
NVSdividend growthlong-term investing
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Intuitive Surgical Posts Double-Digit Growth Despite GLP-1 Drug Market Spotlight

Intuitive Surgical posts double-digit growth in 2025 with 12% installed base expansion and 18% surgery increase, unaffected by GLP-1 drug market competition.
LLYNVOISRGGLP-1 drugsgrowth stocks
The Motley FoolThe Motley Fool··Dave Kovaleski

Healthcare Giants Offer Defensive Appeal Amid Market Correction Concerns

Investors anticipate 2026 market volatility, driving interest in defensive healthcare stocks. AbbVie and Merck offer stable dividends and historical resilience during downturns.
MRKABBVdividend stocksdividend yield